Company Profiles

driven by the PitchBook Platform

Allena Pharmaceuticals

Description

Developer of non-systemic protein therapeutics designed to treat metabolic diseases. The company's non-systemic protein therapeutics reduce the burden of toxic metabolites such as oxalate and uric acid, as well as deliver therapies that are designed to target a specific metabolic compound in the gut without systemic absorption, enabling patients with complex metabolic conditions to get improved treatment.

2011

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$2.67M

Latest Deal Amount

$96M

Total Amount Raised

Description

Developer of non-systemic protein therapeutics designed to treat metabolic diseases. The company's non-systemic protein therapeutics reduce the burden of toxic metabolites such as oxalate and uric acid, as well as deliver therapies that are designed to target a specific metabolic compound in the gut without systemic absorption, enabling patients with complex metabolic conditions to get improved treatment.

Website:

www.allenapharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

One Newton Executive Park Suite 202 Newton, MA 02462United States +1 (617) 467-4577
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Allena Pharmaceuticals's full profile, request a free trial.

Allena Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Allena Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Allena Pharmaceuticals Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Bessemer Venture PartnersVenture CapitalMinority000 0000000 0000
Fidelity Management & ResearchOtherMinority000 0000000 0000
Frazier Healthcare PartnersGrowth/ExpansionMinority000 0000000 0000
HBM PartnersInvestment BankMinority000 0000000 0000
Inbio VenturesVenture CapitalMinority000 0000000 0000
Bessemer Venture Partners Venture Capital
Fidelity Management & Research Other
Frazier Healthcare Partners Growth/Expansion
HBM Partners Investment Bank
Inbio Ventures Venture Capital

Allena Pharmaceuticals Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Louis Brenner MDChief Operating Officer & President
Edward WholihanChief Financial Officer
Annamaria Kausz MDVice President, Clinical Development
Hugh WightVice President, Technical Operations
Robert GallottoCo-Founder
Louis Brenner MD Chief Operating Officer & President
Edward Wholihan Chief Financial Officer
Annamaria Kausz MD Vice President, Clinical Development
Hugh Wight Vice President, Technical Operations
Robert Gallotto Co-Founder

Allena Pharmaceuticals Board Members (7)

NameRepresentingRoleSinceContact
Info
Alexey Margolin Ph.DAllena PharmaceuticalsCo-Founder, Chief Executive Officer & Board Member000 0000
Axel BolteHBM PartnersInvestment Advisor, Private Equity000 0000
Gino SantiniSelfBoard Member000 0000
James Topper Ph.DFrazier Healthcare PartnersManaging General Partner, Life Sciences000 0000
Robert Alexander Ph.DAllena PharmaceuticalsBoard of Director000 0000
Alexey Margolin Ph.D Co-Founder, Chief Executive Officer & Board Member Allena Pharmaceuticals
Axel Bolte Investment Advisor, Private Equity HBM Partners
Gino Santini Board Member Self
James Topper Ph.D Managing General Partner, Life Sciences Frazier Healthcare Partners
Robert Alexander Ph.D Board of Director Allena Pharmaceuticals
Request full access to PitchBook